Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01588834 · ClinicalTrials.gov registry record
Histology of Functional Density in Premenopausal Breast
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 23
- Enrollment target
NCT01588834: Completed study, sponsored by Mayo Clinic.
NCT01588834 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01588834 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
The investigators hypothesize that knowledge of the functional behavior of areas of mammographic density will enable more specific identification of dense tissue at-risk for breast cancer, ultimately providing predictive information on an individual's risk of developing breast cancer.
Interventions
- PROCEDURE breast biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2012-04 |
| Est. Completion | 2016-02 |
What the finished NCT01588834 record still lists
NCT01588834 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 23 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which breast biopsy is the first listed.
NCT01588834 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01588834 about?
NCT01588834 is a clinical study titled "Histology of Functional Density in Premenopausal Breast". The investigators hypothesize that knowledge of the functional behavior of areas of mammographic density will enable more specific identification of dense tissue at-risk for breast cancer, ultimately providing predictive information on an individual's risk of developing breast cancer.
What is the current status of trial NCT01588834?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2012-04. Estimated completion is 2016-02.
What interventions are being tested in trial NCT01588834?
The interventions under investigation include: breast biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT01588834?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia